{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "In passing the new Medicare law, Congress intended to relieve states of prescription drug costs for low-income elderly people. But as states do the arithmetic, many find that they will lose money, because they will have to give back most of the savings to the federal government. The law opened a new chapter in federal-state relations, requiring the states to pay billions of dollars a year to the federal government for a Medicare benefit over which they have no control.", "headline": {"main": "Cost-Cutting Medicare Law Is a Money Loser for States"}, "abstract": "New Medicare law that was intended by Congress to relieve states of prescription drug costs for low-income elderly people will cost states money, because they will have to give back most of savings to federal government; law opens new chapter in federal-state relations, requiring states to pay billions of dollars a year to federal government for Medicare benefit over which they have no control; photos (M)", "print_page": "12", "word_count": 1239, "_id": "4fd283a78eb7c8105d852205", "snippet": "As states do the arithmetic on the new Medicare law, many find that they will have to give back most of the savings to the federal government.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/03/25/politics/25drug.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "UNITED STATES"}, {"name": "subject", "value": "STATES (US)"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "AGED"}, {"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "LAW AND LEGISLATION"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Robert", "rank": 1, "lastname": "PEAR"}], "original": "By ROBERT PEAR"}, "document_type": "article", "pub_date": "2005-03-25T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "Blog", "blog": [], "news_desk": null, "lead_paragraph": "Note: This lesson was originally published on an older version of The Learning Network; the link to the related Times article will take you to a page on the old site.", "headline": {"main": "No New Workers Need Apply", "kicker": "The Learning Network"}, "abstract": "In this lesson, students explore older people's perspectives on work and retirement by creating charts to reflect statistical trends and formulating interview questions. For homework, they write follow-up articles that record and comment on the attitudes of their community's older workers.", "print_page": null, "word_count": 2338, "_id": "4fd363d68eb7c8105d8b27b5", "snippet": "In this lesson, students explore older people's perspectives on work and retirement by creating charts to reflect statistical trends and formulating interview questions. For homework, they write follow-up articles that record and comment on the...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://learning.blogs.nytimes.com/2005/03/24/no-new-workers-need-apply/", "multimedia": [], "subsection_name": null, "keywords": [{"value": "News", "name": "type_of_material", "rank": "1"}], "byline": null, "document_type": "blogpost", "pub_date": "2005-03-24T01:45:00Z", "section_name": "U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "Johnson & Johnson's popular treatment for congestive heart failure, Natrecor, became the latest drug swept up in questions about safety yesterday when an article in the journal Circulation said that the drug had reduced kidney function. An accompanying editorial in the journal, published by the American Heart Association, questioned why the Food and Drug Administration had failed to follow up on concerns about Natrecor's impact on the kidneys and suggested that the drug should have received stronger labeling when it was approved in 2001.", "headline": {"main": "Popular Heart Drug Impairs Kidney Action, Study Says"}, "abstract": "Report published in journal Circulation says Natrecor, Johnson & Johnson's popular treatment for congestive heart failure, reduces kidney function; accompanying editorial questions why Food and Drug Administration failed to follow up on concerns about Natrecor's impact on kidneys and suggests that drug should have received stronger labeling when it was approved in 2001; Johnson & Johnson defends product and criticizes analysis conducted by three cardiologists, saying they relied on data from patients who received higher doses than are now recommended; photo (M)", "print_page": "2", "word_count": 837, "_id": "4fd24a548eb7c8105d7e8806", "snippet": "Johnson & Johnson's popular treatment for congestive heart failure, Natrecor, became the latest drug swept up in questions about safety yesterday when an article in the journal Circulation said that the drug had reduced kidney function.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/03/22/business/22heart.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "JOHNSON & JOHNSON INC"}, {"name": "organizations", "value": "FOOD AND DRUG ADMINISTRATION"}, {"name": "subject", "value": "HEART"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "NATRECOR (DRUG)"}, {"name": "subject", "value": "KIDNEYS"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Stephanie", "rank": 1, "lastname": "SAUL"}], "original": "By STEPHANIE SAUL"}, "document_type": "article", "pub_date": "2005-03-22T00:00:00Z", "section_name": "Health; Business"}], "meta": {"hits": 3, "offset": 0, "time": 41}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}